Exhibit 107
Calculation of Filing Fee Tables
FORM F-3
(Form Type)
NLS Pharmaceutics Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common Shares | Rule 457(o) | (1) (3) | (2) | |||||||||||||||||||||||||||||||||||
| Equity | Warrants | |||||||||||||||||||||||||||||||||||||||
| Equity | Units | |||||||||||||||||||||||||||||||||||||||
| Unallocated Shelf | $75,000,000 | (4) | $ | 0.00015310 | $ | 11,482.50 | ||||||||||||||||||||||||||||||||||
| Fees Previously Paid | ||||||||||||||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 75,000,000 | $ | 11,482.50 | ||||||||||||||||||||||||||||||||||||
| Total Fees Previously Paid | $ | 0.00 | ||||||||||||||||||||||||||||||||||||||
| Total Fee Offsets | $ | 5,929.59 | (5) | |||||||||||||||||||||||||||||||||||||
| Net Fee Due | $ | 5,552.91 | ||||||||||||||||||||||||||||||||||||||
| (1) | There are being registered under this registration statement such indeterminate number of securities as may be sold by the registrant from time to time, which collectively shall have an aggregate initial offering price not to exceed $75,000,000. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the common shares being registered hereunder include such indeterminate number of common shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends, or similar transactions. |
| (2) | Estimated solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act. |
| (3) | Omitted pursuant to Rule 457(o) under the Securities Act. |
| (4) | Estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $75,000,000. |
| (5) | Pursuant to Rule 457(p) under the Securities Act, the registrant hereby offsets the total registration fee due under this registration statement by $5,929.59 (calculated at the fee rate in effect at the date of the registrant’s registration statement on Form F-3 filed by the Registrant with the Securities and Exchange Commission on July 16, 2020 and declared effective on February 11, 2022 (Registration No. 333-262489), or the Prior Registration Statement, which represents the portion of the registration fee previously paid with respect to $63,965,340 of unsold securities previously registered under the Prior Registration Statement). |
Table 2: Fee Offset Claims and Sources
| Registrant of File Name | Form of Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||||||||
| Rule 457(p) | ||||||||||||||||||||||||||||
| Fee Offset Claims | NLS Pharmaceutics Ltd. | F-3 | 333-262489 | February 3, 2022 | $ | 11,482.50 | (1) | Unallocated (Universal) Shelf | Common Shares, Warrants, Units | Unallocated (Universal) Shelf | $ | 63,965,340 | ||||||||||||||||
| Fee Offset Sources | NLS Pharmaceutics Ltd. | F-3 | 333-262489 | February 3, 2022 | $ | 5,929.59 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 457(p) under the Securities Act, the registrant hereby offsets the total registration fee due under this registration statement by $5,929.59 (calculated at the fee rate in effect at the date of the registrant’s Prior Registration Statement), which represents the portion of the registration fee previously paid with respect to $63,965,340 of unsold securities previously registered under the Prior Registration Statement. |
